These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24973218)

  • 1. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
    Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
    J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
    Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
    J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.
    Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M
    J Biol Chem; 2015 Nov; 290(46):27749-66. PubMed ID: 26391394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
    Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
    Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
    Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M
    J Phys Chem B; 2016 Aug; 120(33):8238-53. PubMed ID: 27150586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.
    Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM
    J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.
    Davis J; Wen H; Edwards T; Metzger JM
    J Mol Cell Cardiol; 2008 May; 44(5):891-904. PubMed ID: 18423659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
    Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
    Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.
    Li Y; Zhang L; Jean-Charles PY; Nan C; Chen G; Tian J; Jin JP; Gelb IJ; Huang X
    J Mol Cell Cardiol; 2013 Sep; 62():227-36. PubMed ID: 23810866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy mutations increase myofilament Ca
    Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
    J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L-type Ca(2+) channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy.
    Viola H; Johnstone V; Cserne Szappanos H; Richman T; Tsoutsman T; Filipovska A; Semsarian C; Hool L
    J Physiol; 2016 Jul; 594(14):4051-70. PubMed ID: 27062056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
    Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
    J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
    J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.
    Kumar M; Govindan S; Zhang M; Khairallah RJ; Martin JL; Sadayappan S; de Tombe PP
    J Biol Chem; 2015 Dec; 290(49):29241-9. PubMed ID: 26453301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.
    Cazorla O; Szilagyi S; Vignier N; Salazar G; Krämer E; Vassort G; Carrier L; Lacampagne A
    Cardiovasc Res; 2006 Feb; 69(2):370-80. PubMed ID: 16380103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
    Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
    J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.